What Can We Do to Refine the Redundant Data in LC–MS and GC–MS Based Metabolomics?
Jiaqing Chen,Fengguo Xu
DOI: https://doi.org/10.4155/bio-2016-0272
IF: 2.695
2017-01-01
Bioanalysis
Abstract:BioanalysisVol. 9, No. 3 EditorialWhat can we do to refine the redundant data in LC–MS and GC–MS based metabolomics?Jiaqing Chen & Fengguo XuJiaqing Chen Key Laboratory of Drug Quality Control & Pharmacovigilance, China Pharmaceutical University, Nanjing 210009, PR China State Key Laboratory of Natural Medicine, China Pharmaceutical University, Nanjing 210009, PR ChinaSearch for more papers by this author & Fengguo Xu*Author for correspondence: E-mail Address: fengguoxu@gmail.com Key Laboratory of Drug Quality Control & Pharmacovigilance, China Pharmaceutical University, Nanjing 210009, PR China State Key Laboratory of Natural Medicine, China Pharmaceutical University, Nanjing 210009, PR ChinaSearch for more papers by this authorPublished Online:13 Jan 2017https://doi.org/10.4155/bio-2016-0272AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: data refinementmetabolomicsMSReferences1 Kohler I, Verhoeven A, Derks RJ, Giera M. Analytical pitfalls and challenges in clinical metabolomics. Bioanalysis 8(14), 1509–1532 (2016).Link, CAS, Google Scholar2 Coble JB, Fraga CG. Comparative evaluation of preprocessing freeware on chromatography/mass spectrometry data for signature discovery. J. Chromatogr. A 1358, 155–164 (2014).Crossref, Medline, CAS, Google Scholar3 Niu WH, Knight E, Xia Q, Mcgarvey BD. Comparative evaluation of eight software programs for alignment of gas chromatography-mass spectrometry chromatograms in metabolomics experiments. J. Chromatogr. A 1374, 199–206 (2014).Crossref, Medline, CAS, Google Scholar4 Gao Y, Zhang R, Bai J et al. Targeted data-independent acquisition and mining strategy for trace drug metabolite identification using liquid chromatography coupled with tandem mass spectrometry. Anal. Chem. 87(15), 7535–7539 (2015).Crossref, Medline, CAS, Google Scholar5 Gu H, Zhang P, Zhu J, Raftery D. Globally optimized targeted mass spectrometry: reliable metabolomics analysis with broad coverage. Anal. Chem. 87(24), 12355–12362 (2015).Crossref, Medline, CAS, Google Scholar6 Zhu X, Chen Y, Subramanian R. Comparison of information-dependent acquisition, SWATH and MS(All) techniques in metabolite identification study employing ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. Anal. Chem. 86(2), 1202–1209 (2014).Crossref, Medline, CAS, Google Scholar7 Egertson JD, Kuehn A, Merrihew GE et al. Multiplexed MS/MS for improved data-independent acquisition. Nat. Methods 10(8), 744–746 (2013).Crossref, Medline, CAS, Google Scholar8 Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat. Protoc. 7(5), 872–881 (2012).Crossref, Medline, CAS, Google Scholar9 Bonner R, Hopfgartner G. SWATH acquisition mode for drug metabolism and metabolomics investigations. Bioanalysis 8(16), 1735–1750 (2016).Link, CAS, Google Scholar10 Tsugawa H, Cajka T, Kind T et al. MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat. Methods 12(6), 523–526 (2015).Crossref, Medline, CAS, Google Scholar11 Chen S, Kong H, Lu X et al. Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography/triple quadrupole mass spectrometry. Anal. Chem. 85(17), 8326–8333 (2013).Crossref, Medline, CAS, Google Scholar12 Luo P, Dai W, Yin P et al. Multiple reaction monitoring-ion pair finder: a systematic approach to transform nontargeted mode to pseudotargeted mode for metabolomics study based on liquid chromatography–mass spectrometry. Anal. Chem. 87(10), 5050–5055 (2015).Crossref, Medline, CAS, Google Scholar13 Rasche F, Svatos A, Maddula RK, Bottcher C, Bocker S. Computing fragmentation trees from tandem mass spectrometry data. Anal. Chem. 83(4), 1243–1251 (2011).Crossref, Medline, CAS, Google Scholar14 Kuhl C, Tautenhahn R, Boettcher C, Larson TR, Neumann S. CAMERA: an integrated strategy for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets. Anal. Chem. 84(1), 283–289 (2012).Crossref, Medline, CAS, Google Scholar15 Lynn KS, Cheng ML, Chen YR et al. Metabolite identification for mass spectrometry-based metabolomics using multiple types of correlated ion information. Anal. Chem. 87(4), 2143–2151 (2015).Crossref, Medline, CAS, Google Scholar16 Zeng Z, Liu X, Dai W et al. Ion fusion of high-resolution LC-MS-based metabolomics data to discover more reliable biomarkers. Anal. Chem. 86(8), 3793–3800 (2014).Crossref, Medline, CAS, Google Scholar17 Ara T, Sakurai N, Tange Y et al. Improvement of the quantitative differential metabolome pipeline for gas chromatography-mass spectrometry data by automated reliable peak selection. Plant Biotechnol. 26(5), 445–449 (2009).Crossref, CAS, Google Scholar18 Fernandez-Albert F, Llorach R, Andres-Lacueva C, Perera-Lluna A. Peak aggregation as an innovative strategy for improving the predictive power of LC–MS metabolomic profiles. Anal. Chem. 86(5), 2320–2325 (2014).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByEconomic Scheduling Problem of Nanomaterial Import and Export Trade Based on Redundant Data Compression Algorithm and Its Parameter Adjustment MethodAdvances in Materials Science and Engineering, Vol. 2022Influences of Normalization Method on Biomarker Discovery in Gas Chromatography–Mass Spectrometry-Based Untargeted Metabolomics: What Should Be Considered?24 April 2017 | Analytical Chemistry, Vol. 89, No. 10 Vol. 9, No. 3 Follow us on social media for the latest updates Metrics Downloaded 165 times History Published online 13 January 2017 Published in print February 2017 Information© Future Science LtdKeywordsdata refinementmetabolomicsMSFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download